Skip header and navigation
CMA PolicyBase

Policies that advocate for the medical profession and Canadians


40 records – page 1 of 2.

Socially responsible investing

https://policybase.cma.ca/en/permalink/policy13718
Last Reviewed
2020-02-29
Date
2017-08-23
Topics
Physician practice/ compensation/ forms
Resolution
GC17-20
The Canadian Medical Association recommends that MD Financial Management Inc. provide information regarding socially responsible investing when marketing and advising on its investment portfolios.
Policy Type
Policy resolution
Last Reviewed
2020-02-29
Date
2017-08-23
Topics
Physician practice/ compensation/ forms
Resolution
GC17-20
The Canadian Medical Association recommends that MD Financial Management Inc. provide information regarding socially responsible investing when marketing and advising on its investment portfolios.
Text
The Canadian Medical Association recommends that MD Financial Management Inc. provide information regarding socially responsible investing when marketing and advising on its investment portfolios.
Less detail

Excise duty framework for cannabis products

https://policybase.cma.ca/en/permalink/policy13799
Date
2017-12-07
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
  1 document  
Policy Type
Response to consultation
Date
2017-12-07
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Text
The Canadian Medical Association (CMA) is pleased to provide its comments with respect to the Government of Canada's consultation on the Proposed Excise Duty Framework for Cannabis Products published November 10.1 In the move towards the legalization and regulation of cannabis, there are many economic interests at play; private corporations and different levels of government stand to benefit greatly with sales and considerable tax revenue.2 It is essential that the federal and provincial/territorial governments be held accountable to the public health and safety objectives set out for the new regime for legal access to cannabis, particularly that of protecting children and youth.3 It is fundamental that commercialization is rigorously controlled through taxation, regulation, monitoring and advertising controls. Final pricing must be such as to discourage the illegal production and trafficking of cannabis. However, a balance must be found with the use of taxation and pricing levers to discourage use. Revenues need to be clearly earmarked to cover the health and social costs of legalization. In some U.S. jurisdictions, for example, some of the revenue is directed to recovering the costs of regulatory programs as well as in substance use treatment programs, and for social programs. Most of the future tax revenues should be redistributed to the provinces and territories. This is because they have jurisdiction over services that will likely feel the impact with legalization, such as health care, education, social and other services, as well as enforcement of legislation and regulations. A public health approach to legalization will emphasize prevention, education and treatment initiatives which require adequate and reliable funding. It will also require strong surveillance and monitoring activities to adjust measures should unintended harms be detected. Resources need to be promptly available to address potential negative impacts. CMA recommends that the revenue resulting from the taxation of cannabis production and sales be earmarked to address health and social harms of cannabis use and its commercialization, in line with a public health approach to the legalization of cannabis. The proposal states that "Any cannabis products sold under the proposed Cannabis Act for medical purposes will be subject to the duty rates and conditions of the excise duty framework, which will become applicable as per the transitional rules (...) Cannabis products that are produced by an individual (or a designated person) for the individual's own medical purposes in accordance with the proposed Cannabis Act will not be subject to the excise duty. Seeds and seedlings used in this production will be subject to duty."1 The CMA is supportive of similar taxation treatment of cannabis products, regardless of whether they are used for medical or non-medical purposes. The CMA has long called for more research to better understand potential therapeutic indications of cannabis, as well as its risks.4 5 Physicians recognize that some individuals suffering from terminal illness or chronic disease for which conventional therapies have not been effective may obtain relief with cannabis used for medical purposes. However, clinical evidence of medical benefits is limited and there is very limited guidance for the therapeutic use, including indications, potency, interactions with medications and adverse effects. Health Canada does not approve of cannabis as a medicine, as it has not gone through the approvals required by the regulatory process to be a pharmaceutical. It is important that there be support for cannabis research in order to develop products that can be held to pharmaceutical standards, as is the case with dronabinol (Marinol(r)), nabilone (Cesamet(r)) and THC/CBD (Sativex(r)). The experience of legalization for non-medical use in Colorado and Washington has shown that two separate regimes with distinct regulations can be very difficult to enforce given the different standards.6 A lower tax rate on cannabis for medical use could potentially provide an incentive for people to seek a medical authorization, and that was observed initially in Colorado.7 The CMA recommends that the same tax rates be applied to the production and sales of both the medical and the non-medical use of cannabis products. The move towards the legalization and regulation of cannabis will require a balanced approach to discourage the illegal production and trafficking of cannabis while also using taxation and pricing levers to discourage use. Much of the revenues raised should be redistributed to the provinces and territories to enable them to cover the health and social costs of legalization. A public health approach to legalization will emphasize prevention, education, treatment and surveillance initiatives which requires adequate and reliable funding. 1 Department of Finance Canada. Proposed excise duty framework for cannabis products. Ottawa: Department of Finance Canada; 2017. Available: http://www.fin.gc.ca/n17/data/17-114_1-eng.asp (accessed 2017 Dec 05). 2 Sen A, Wyonch R. Don't (over) tax that joint, my friend. Intelligence MEMOS. Ottawa: CD Howe Institute; 2017 Jul 19. Available: https://www.cdhowe.org/sites/default/files/blog_Anindya%20and%20Rosalie_0719.pdf (accessed 2017 Dec 06). 3 Task Force on Marijuana Legalization and Regulation. Ministry of Justice, Ministry of Public Safety and Emergency Preparedness and Ministry of Health. Toward the legalization, regulation and restriction of access to marijuana. Discussion paper. Ottawa: Cannabis Legalization and Regulation Secretariat; 2016. Available: http://www.healthycanadians.gc.ca/health-system-systeme-sante/consultations/legalization-marijuana-legalisation/alt/legalization-marijuana-legalisation-eng.pdf (accessed 2017 Dec 05). 4 Canadian Medical Association (CMA). A public health perspective on cannabis and other illegal drugs. CMA Submission to the Special Senate Committee on Illegal Drugs. Ottawa: CMA; 2002. Available: https://www.cma.ca/Assets/assets-library/document/en/advocacy/cannabis.pdf (accessed 2017 Dec 05). 5 Canadian Medical Association (CMA). Medical Marijuana. CMA Policy. Ottawa: CMA; 2011. Available: https://www.cma.ca/Assets/assets-library/document/en/advocacy/PD11-02-e.pdf (accessed 2017 Dec 05). 6 Canadian Centre on Substance Use and Addiction (CCSA). Cannabis regulation: Lessons learned in Colorado and Washington State. Ottawa: CCSA; 2015. Available: http://www.ccsa.ca/Resource%20Library/CCSA-Cannabis-Regulation-Lessons-Learned-Report-2015-en.pdf (accessed 2017 Dec 05). 7 Office of the Parliamentary Budget Officer. Legalized cannabis: Fiscal considerations. Ottawa: Office of the Parliamentary Budget Officer; 2016. Available: http://www.pbo-dpb.gc.ca/web/default/files/Documents/Reports/2016/Legalized%20Cannabis/Legalized%20Canabis%20Fiscal%20Considerations_EN.pdf (accessed 2017 Dec 05).
Documents
Less detail

Care to new immigrants and refugees

https://policybase.cma.ca/en/permalink/policy13699
Date
2017-08-23
Topics
Health systems, system funding and performance
Population health/ health equity/ public health
Resolution
GC17-04
The Canadian Medical Association supports development of clinical best practice guidelines for the provision of care to new immigrants and refugees.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Health systems, system funding and performance
Population health/ health equity/ public health
Resolution
GC17-04
The Canadian Medical Association supports development of clinical best practice guidelines for the provision of care to new immigrants and refugees.
Text
The Canadian Medical Association supports development of clinical best practice guidelines for the provision of care to new immigrants and refugees.
Less detail

National recognition of physician administrators/executives

https://policybase.cma.ca/en/permalink/policy13700
Date
2017-08-23
Topics
Physician practice/ compensation/ forms
Resolution
GC17-14
The Canadian Medical Association supports national recognition of physician administrators/executives with initiatives designed to recognize and support their contributions.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Physician practice/ compensation/ forms
Resolution
GC17-14
The Canadian Medical Association supports national recognition of physician administrators/executives with initiatives designed to recognize and support their contributions.
Text
The Canadian Medical Association supports national recognition of physician administrators/executives with initiatives designed to recognize and support their contributions.
Less detail

Clinical care for physician administrators/executives

https://policybase.cma.ca/en/permalink/policy13701
Date
2017-08-23
Topics
Physician practice/ compensation/ forms
Health human resources
Resolution
GC17-15
The Canadian Medical Association recognizes the importance of continued involvement in the provision of clinical care for physician administrators/executives, and encourages organizations employing these physicians to provide clinical practice opportunities.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Physician practice/ compensation/ forms
Health human resources
Resolution
GC17-15
The Canadian Medical Association recognizes the importance of continued involvement in the provision of clinical care for physician administrators/executives, and encourages organizations employing these physicians to provide clinical practice opportunities.
Text
The Canadian Medical Association recognizes the importance of continued involvement in the provision of clinical care for physician administrators/executives, and encourages organizations employing these physicians to provide clinical practice opportunities.
Less detail

International commercial surrogacy

https://policybase.cma.ca/en/permalink/policy13702
Date
2017-08-23
Topics
Health care and patient safety
Population health/ health equity/ public health
Resolution
GC17-05
The Canadian Medical Association supports advocacy efforts to increase awareness of the physical and mental health risks associated with international commercial surrogacy.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Health care and patient safety
Population health/ health equity/ public health
Resolution
GC17-05
The Canadian Medical Association supports advocacy efforts to increase awareness of the physical and mental health risks associated with international commercial surrogacy.
Text
The Canadian Medical Association supports advocacy efforts to increase awareness of the physical and mental health risks associated with international commercial surrogacy.
Less detail

Opioid overdose prevention supplies available in publicly accessible locations

https://policybase.cma.ca/en/permalink/policy13703
Date
2017-08-23
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC17-06
The Canadian Medical Association supports making naloxone and other opioid overdose prevention supplies available in publicly accessible locations.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC17-06
The Canadian Medical Association supports making naloxone and other opioid overdose prevention supplies available in publicly accessible locations.
Text
The Canadian Medical Association supports making naloxone and other opioid overdose prevention supplies available in publicly accessible locations.
Less detail

Cultural awareness

https://policybase.cma.ca/en/permalink/policy13704
Date
2017-08-23
Topics
Ethics and medical professionalism
Health care and patient safety
Resolution
GC17-16
The Canadian Medical Association encourages medical licensing bodies to require registrants to have training in cultural awareness.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Ethics and medical professionalism
Health care and patient safety
Resolution
GC17-16
The Canadian Medical Association encourages medical licensing bodies to require registrants to have training in cultural awareness.
Text
The Canadian Medical Association encourages medical licensing bodies to require registrants to have training in cultural awareness.
Less detail

Management of chronic pain in older adults

https://policybase.cma.ca/en/permalink/policy13705
Date
2017-08-23
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC17-07
The Canadian Medical Association supports increased approval and funding of pharmacologic options for the management of chronic pain in older adults.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC17-07
The Canadian Medical Association supports increased approval and funding of pharmacologic options for the management of chronic pain in older adults.
Text
The Canadian Medical Association supports increased approval and funding of pharmacologic options for the management of chronic pain in older adults.
Less detail

Nutritional guidelines in Canadian schools

https://policybase.cma.ca/en/permalink/policy13706
Date
2017-08-23
Topics
Health care and patient safety
Population health/ health equity/ public health
Resolution
GC17-08
The Canadian Medical Association supports mandatory adherence to national or province/territoryspecific nutritional guidelines in Canadian schools, including a means to monitor and report school compliance.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Health care and patient safety
Population health/ health equity/ public health
Resolution
GC17-08
The Canadian Medical Association supports mandatory adherence to national or province/territoryspecific nutritional guidelines in Canadian schools, including a means to monitor and report school compliance.
Text
The Canadian Medical Association supports mandatory adherence to national or province/territoryspecific nutritional guidelines in Canadian schools, including a means to monitor and report school compliance.
Less detail

Federal Genetic Non-Discrimination Act

https://policybase.cma.ca/en/permalink/policy13707
Date
2017-08-23
Topics
Ethics and medical professionalism
Health care and patient safety
Resolution
GC17-09
The Canadian Medical Association urges provincial and territorial governments to support the Federal Genetic Non-Discrimination Act (Bill S-201) by enacting corresponding legislation that echoes privacy protection.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Ethics and medical professionalism
Health care and patient safety
Resolution
GC17-09
The Canadian Medical Association urges provincial and territorial governments to support the Federal Genetic Non-Discrimination Act (Bill S-201) by enacting corresponding legislation that echoes privacy protection.
Text
The Canadian Medical Association urges provincial and territorial governments to support the Federal Genetic Non-Discrimination Act (Bill S-201) by enacting corresponding legislation that echoes privacy protection.
Less detail

Victims of human trafficking

https://policybase.cma.ca/en/permalink/policy13708
Date
2017-08-23
Topics
Ethics and medical professionalism
Health care and patient safety
Resolution
GC17-17
The Canadian Medical Association supports increased physician awareness and education in identifying and supporting victims of human trafficking.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Ethics and medical professionalism
Health care and patient safety
Resolution
GC17-17
The Canadian Medical Association supports increased physician awareness and education in identifying and supporting victims of human trafficking.
Text
The Canadian Medical Association supports increased physician awareness and education in identifying and supporting victims of human trafficking.
Less detail

Federal excise tax on sugar-sweetened beverages and artificially-sweetened drinks

https://policybase.cma.ca/en/permalink/policy13709
Date
2017-08-23
Topics
Health care and patient safety
Resolution
GC17-10
The Canadian Medical Association calls on the federal government to implement a federal excise tax on sugar-sweetened beverages and artificially-sweetened drinks sold in Canada to subsidize healthier food options.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Health care and patient safety
Resolution
GC17-10
The Canadian Medical Association calls on the federal government to implement a federal excise tax on sugar-sweetened beverages and artificially-sweetened drinks sold in Canada to subsidize healthier food options.
Text
The Canadian Medical Association calls on the federal government to implement a federal excise tax on sugar-sweetened beverages and artificially-sweetened drinks sold in Canada to subsidize healthier food options.
Less detail

Antimicrobial stewardship and antimicrobial resistance surveillance

https://policybase.cma.ca/en/permalink/policy13710
Date
2017-08-23
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC17-11
The Canadian Medical Association calls on the federal government to use Canada’s term as G7 President in 2018 to add antimicrobial stewardship and antimicrobial resistance surveillance as part of their agenda.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC17-11
The Canadian Medical Association calls on the federal government to use Canada’s term as G7 President in 2018 to add antimicrobial stewardship and antimicrobial resistance surveillance as part of their agenda.
Text
The Canadian Medical Association calls on the federal government to use Canada’s term as G7 President in 2018 to add antimicrobial stewardship and antimicrobial resistance surveillance as part of their agenda.
Less detail

Lack of access to insured health services

https://policybase.cma.ca/en/permalink/policy13711
Date
2017-08-23
Topics
Population health/ health equity/ public health
Health systems, system funding and performance
Resolution
GC17-12
The Canadian Medical Association calls on governments to address the lack of access to insured health services for those residing in Canada, regardless of immigration status.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Population health/ health equity/ public health
Health systems, system funding and performance
Resolution
GC17-12
The Canadian Medical Association calls on governments to address the lack of access to insured health services for those residing in Canada, regardless of immigration status.
Text
The Canadian Medical Association calls on governments to address the lack of access to insured health services for those residing in Canada, regardless of immigration status.
Less detail

National guide on levels of medical intervention

https://policybase.cma.ca/en/permalink/policy13712
Date
2017-08-23
Topics
Health systems, system funding and performance
Resolution
GC17-18
The Canadian Medical Association will develop a national guide on levels of medical intervention for use across the continuum of care.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Health systems, system funding and performance
Resolution
GC17-18
The Canadian Medical Association will develop a national guide on levels of medical intervention for use across the continuum of care.
Text
The Canadian Medical Association will develop a national guide on levels of medical intervention for use across the continuum of care.
Less detail

A review of Canada’s medical liability system

https://policybase.cma.ca/en/permalink/policy13713
Date
2017-08-23
Topics
Health systems, system funding and performance
Resolution
GC17-19
The Canadian Medical Association supports a review of Canada’s medical liability system and an evaluation of alternative models.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Health systems, system funding and performance
Resolution
GC17-19
The Canadian Medical Association supports a review of Canada’s medical liability system and an evaluation of alternative models.
Text
The Canadian Medical Association supports a review of Canada’s medical liability system and an evaluation of alternative models.
Less detail

Mandatory labelling, warnings and a recall system for prescription pharmaceuticals

https://policybase.cma.ca/en/permalink/policy13714
Date
2017-08-23
Topics
Population health/ health equity/ public health
Health care and patient safety
Resolution
GC17-24
The Canadian Medical Association calls for mandatory labelling, warnings and a recall system for prescription pharmaceuticals sold in Canada that contain gluten and/or priority allergens.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Population health/ health equity/ public health
Health care and patient safety
Resolution
GC17-24
The Canadian Medical Association calls for mandatory labelling, warnings and a recall system for prescription pharmaceuticals sold in Canada that contain gluten and/or priority allergens.
Text
The Canadian Medical Association calls for mandatory labelling, warnings and a recall system for prescription pharmaceuticals sold in Canada that contain gluten and/or priority allergens.
Less detail

Awareness of the difference between financial/insurance advisers

https://policybase.cma.ca/en/permalink/policy13715
Date
2017-08-23
Topics
Physician practice/ compensation/ forms
Resolution
GC17-21
The Canadian Medical Association will work with stakeholders in medical education to encourage awareness of the difference between non-commissioned financial/insurance advisers employed by national and provincial/territorial medical associations and commissioned financial/insurance advisers employed by banks and other corporations.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Physician practice/ compensation/ forms
Resolution
GC17-21
The Canadian Medical Association will work with stakeholders in medical education to encourage awareness of the difference between non-commissioned financial/insurance advisers employed by national and provincial/territorial medical associations and commissioned financial/insurance advisers employed by banks and other corporations.
Text
The Canadian Medical Association will work with stakeholders in medical education to encourage awareness of the difference between non-commissioned financial/insurance advisers employed by national and provincial/territorial medical associations and commissioned financial/insurance advisers employed by banks and other corporations.
Less detail

Electronic portal for medical organization

https://policybase.cma.ca/en/permalink/policy13716
Date
2017-08-23
Topics
Population health/ health equity/ public health
Resolution
GC17-22
The Canadian Medical Association will create an electronic portal to allow medical organizations to upload their contact information.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Population health/ health equity/ public health
Resolution
GC17-22
The Canadian Medical Association will create an electronic portal to allow medical organizations to upload their contact information.
Text
The Canadian Medical Association will create an electronic portal to allow medical organizations to upload their contact information.
Less detail

40 records – page 1 of 2.